Virtual Patient: Young Child with Allergy to Grass Pollen
This course provides a case simulation that involves evaluation and management of a young child with seasonal allergic rhinitis with allergen immunotherapy (AIT). The benefits and risks of AIT in general in the context of a young child will be reviewed, and a summary of AIT literature supporting best practices will be provided.
Making IT Count is funded through an educational grant from Merck & Co., Inc.
- Allied Health providers
Upon completion of this activity, participants should be able to:
- Identify the benefits and risks/harms of Allergen Immunotherapy (AIT) in childhood
- Compare the duration, administration, efficacy, safety, and cost effectiveness of different types of AIT
- Explain necessary follow-up treatment
Linda Cox, MD FAAAAI
Allergy and Asthma Center, Fort Lauderdale, FL
Relevant relationships: Current Treatment options in Allergy: Immunotherapy section editor; Sublingual Immunotherapy Joint Task Force Co-chair; ACAAI Chair Immunotherapy and Diagnostic Committee; Member of the Joint Task Force of Practice Parameters
Anna H. Nowak-Wegrzyn, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Merck - Advisory board
Jeanette Arnold, MSN RN C-FNP
University of Mississippi Medical Center, Jackson MS
Relevant relationships: None
Gloria E. Akan, MD
ENTAA Care, Lanham, MD
Relevant relationships: None
Jeanne E. Conner, NP
Medical College of Wisconsin, Milwaukee, WI
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Original release date: March 5, 2016. Reviewed by Anna Nowak-Wegrzyn, MD FAAAAI on February 2, 2018. Valid for credit through March 4, 2020.
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 0.25 Contact Hours.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME Info and Disclosure information.
- Complete all required components.
- Complete the Commitment to Change form.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at firstname.lastname@example.org.
- 0.25 AttendanceAttendance credit.
- 0.25 CECE credit.
- 0.25 CMECME credit.
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari. Internet Explorer is not recommended.
Pop-ups must be enabled in order to access all course content. The course will pop-up in a new window.
When you finish the course, you must close the pop-up in order to move forward.